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Edited by Amy McGoughAbstract Palladin is a novel component of stress ﬁber dense
regions. Antisense and transient overexpression studies have
indicated an important role for palladin in the regulation of actin
cytoskeleton. Palladin colocalizes and coimmunoprecipitates
with a-actinin, a dense region component, but the molecular
details and functional signiﬁcance of the interaction have not
been studied. We show here a direct association between the two
proteins and have mapped the binding site within a short
sequence of palladin and in the carboxy-terminal calmodulin
domain of a-actinin. Using transfection-based targeting assays,
we show that palladin is involved in targeting of a-actinin to
speciﬁc subcellular foci indicating a functional interplay between
the two actin-associated proteins.
 2004 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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Actin-binding protein1. Introduction
Actin cytoskeleton is an essential structural and functional
element that controls cell shape and movement. In order to
perform its functions, the cytoskeleton must form highly or-
ganized dynamic structures, such as stress ﬁbers and lamelli-
podia. When cellular needs are changed, these structures are
disassembled and remodeled to meet the new requirements.
The process is swift and tightly regulated by diﬀerent temporal
and spatial cues. The assembly, maintenance and disassembly
of actin cytoskeleton is mediated by a variety of actin-associ-
ated proteins with divergent molecular interactions and func-
tional properties.
One of the ubiquitously expressed actin-organizing mole-
cules is a-actinin, a ﬁlament cross-linking protein. It consists of
an amino-terminal actin-binding region, a rod domain with
four spectrin repeats and a calmodulin EF-hand-like domain
at the carboxy-terminus [1–3]. In skeletal muscle sarcomere, a-
actinin is a key structural component of the Z-disc, a complex
protein assembly, in which actin ﬁlaments are anchored and* Corresponding author. Fax: +358-9-4717-1964.
E-mail address: mikko.ronty@helsinki.ﬁ (M. R€onty).
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doi:10.1016/j.febslet.2004.04.006aligned. a-Actinin interacts with several Z-disc components,
including titin, myotilin and myopalladin, all of which contain
C2-type Ig-like domains [4–6]. In non-muscle cells, a-actinin is
characteristically localized to focal adhesions, membrane
protrusions and dense regions along actin stress ﬁbers. Al-
though the signiﬁcance of dense regions is not well understood,
they are considered to be the non-muscle equivalent of Z-discs
[7]. Besides a-actinin, dense regions contain vasodilator-stim-
ulated phosphoprotein (VASP), palladin and sometimes zyxin
[8–11]. a-Actinin can also bind several transmembrane
proteins such as integrin b-subunits, ICAM-1 and -2 and L-
selectin [12–15]. Thus, both in muscle and non-muscle cells,
a-actinin is an important cytoskeleton-organizing protein,
which acts as an adaptor in multi-protein complexes associated
with actin ﬁlaments [1]. The molecular interactions involved in
targeting of a-actinin, e.g., to dense regions are not known.
Palladin, together with myotilin and myopalladin, forms a
novel subfamily of cytoskeletal Ig-domain-containing proteins
[5,6,10,11]. Myotilin contains two carboxy-terminal C2-type
Ig-domains, while myopalladin has two amino-terminal and
three carboxy-terminal Ig-domains and the published human
and mouse palladin sequence contains three carboxy-terminal
Ig-domains [5,6,10,11]. The amino-terminus of palladin con-
tains regions with similarity to myotilin, but also unique se-
quence including two poly-proline stretches with putative
interaction sites for other actin-organizing proteins. Myotilin
and myopalladin are mainly expressed in striated muscle,
whereas palladin is more widely expressed both in epithelial
and mesenchymal cells. Both myotilin and myopalladin play
important roles in maintaining the structural integrity of the
sarcomere, and myotilin mutations lead to limb-girdle mus-
cular dystrophy (LGMD1A), characterized by marked Z-disc
alterations [16]. Myotilin and myopalladin directly interact
with a-actinin, although apparently via diﬀerent regions [5,6].
In addition, myotilin binds actin and bundles actin in coor-
dination with a-actinin [17]. Based on coimmunoprecipitation
and colocalization studies, palladin also is in complex with a-
actinin [10].
Due to its high sequence homology to myotilin and myo-
palladin, palladin is presumed to play a role in maintenance
and modulation of actin cytoskeleton in non-muscle tissues. In
line with this idea, palladin is localized to focal adhesions and
actin stress ﬁber dense regions, where it colocalizes with a-
actinin [10,11]. Down-regulation of palladin expression leads
to loss of stress ﬁbers [18] and increased palladin expression is
associated with cytoskeletal reorganization in dendritic cells,
trophoblastic cells and astrocytes [10,11,19]. In order to betterblished by Elsevier B.V. All rights reserved.
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Fig. 1. Yeast two hybrid of analysis of palladin–a-actinin interaction. (A) Mapping of the a-actinin interaction site in palladin. Yeast cells were
cotransformed with various palladin fragments in bait vector and a-actinin R3R4-EF or full length a-actinin in prey vector. Interactions between
constructs were monitored by scoring growth on plates lacking histidine and by a ﬁlter based b-galactosidase assay. Amino acids 222–280 are
necessary and suﬃcient for the interaction with a-actinin. The carboxy-terminal sequence (275–772) does not bind a-actinin. (B) Mapping of the
palladin interaction site in a-actinin. Overlapping a-actinin constructs were tested for interaction with palladin. Results for palladin 101–772 are
shown but identical results were obtained with other constructs shown to bind a-actinin in (A). The interaction is mediated by the second EF-hand
(EF3/4) in the carboxy-terminal part of a-actinin.
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the molecular details and functional consequences of the in-
teraction between palladin and a-actinin.2. Materials and methods
2.1. Palladin constructs
Palladin constructs were PCR ampliﬁed using expressed sequence
tags, EST Ab023209 and EST93367 (corresponds to NM_016081)
cDNA as templates, and subcloned into pLexA vector for yeast two
hybrid experiments and into pAHP or EGFP vectors for mammalian
expression. For mitochondrial outer membrane (MOM) targeting, se-
quences encoding for palladin residues 8–387 and 222–280 were sub-
cloned into pCDNA3-MOM-BiPro vector provided by B. Jockush [20].
For in vitro translation, palladin constructs 8–772 pAHP, 101–280
pAHP and 389–772 pAMC were used. The identity of all derived
constructs was veriﬁed by DNA sequencing. Human muscle a-actinin
2A constructs (provided by P. Young and M. Gautel) for yeast two
hybrid analysis were cloned into pGAD10 prey vector. A human a-
actinin 1 construct, in which the rod and EF-hand-domains (R1–R4EF)
are joined to green ﬂuorescent protein (GFP), has been described [21].Fig. 2. Aﬃnity precipitation analysis of palladin–a-actinin interaction.
GST–a-actinin constructs coupled to glutathione–Sepharose beads
were reacted with in vitro translated 35S-labeled palladin fragments.
Left panel is a Coomassie blue staining of the a-actinin constructs.
Right panel is an autoradiograph showing the palladin probes and
material eluted from beads. Palladin 8–772 and 101–280 constructs
bind to carboxy-terminal GST–a-actinin R3R4EF fusion protein,
whereas PP389–772 does not bind.2.2. Yeast two-hybrid analysis
Bait and prey constructs were cotransformed into Saccharomyces
cerevisiae L40 reporter strain using a modiﬁed lithium acetate proto-
col. Transformants were plated onto synthetic medium lacking leucine
and tryptophan. Activation of the His 3 reporter gene was assayed by
restreaking yeast on plates lacking histidine, leucine, tryptophan, uraciland lysine and incubating them for 3 days at 30 C. His+ colonies were
grown on synthetic medium lacking leucine and tryptophan for 3 days
at 30 C and assayed for b-galactosidase activity by a ﬁlter assay.
Fig. 3. Sequence alignment of the palladin and myotilin a-actinin interacting regions. Residues 80–125 of myotilin and 222–280 of palladin were
aligned using the ClustalW program. Double stars depict identical residues, stars depict conservative changes. A highly homologous 17 amino-acid
segment (amino acids 89–105 of myotilin and 235–251 of palladin) can be identiﬁed and is boxed.
32 M. R€onty et al. / FEBS Letters 566 (2004) 30–342.3. In vitro translation and aﬃnity precipitation assay
HA- (8–772, 101–280) or Myc-tagged (389–772) palladin constructs
were in vitro translated using a rabbit reticulocyte T7 kit (Promega).
GST-coupled chicken gizzard a-actinin 1 constructs, ABD-R1R2 and
R3R4-EF [22], were produced in Escherichia coli strain BL21 and
puriﬁed using glutathione beads (Pharmacia). For aﬃnity precipita-
tion, 5 ll of 35S-Met labeled in vitro translated palladin constructs
mixed with equal amount of GST–a-actinin or GST beads in binding
buﬀer (10 mM Tris–HCl, pH7.4, 150 mMNaCl, 1 mMMgCl2, and 1%
Triton X-100). After 2 h incubation at +4 C, the beads were washed
three times and harvested in Laemmli buﬀer. Bound proteins were
resolved in 10% SDS–PAGE gels and detected by autoradiography.
2.4. Cell cultures, transfections and immunoﬂuorescence microscopy
U251, COS-7 and CHO cells were transfected using FuGENE 6
(Roche Diagnostics). After 24–48 h, cells grown on glass coverslips
were ﬁxed in 3.5% PFA, permeabilized with 0.1% Triton X-100 and
stained. For detection of the mitochondrially targeted constructs, the
Bi-Pro tag mAb 4A6 [20] was used, followed by detection with Alexa
568 anti-mouse Ig (Molecular Probes). F-actin was detected with
TRITC-labeled phalloidin (Molecular Probes). Endogenous a-actinin
was stained with monoclonal BM75.2 IgM antibody (Sigma) and
rhodamine-conjugated anti-mouse IgM (Jackson Immunoresearch)
was used for detection. Specimens were analyzed in Zeiss Axiophot
ﬂuorescence microscope equipped with AxioCam cooled CCD-camera.Fig. 4. Localization of GFP–palladin constructs in U251 cells. GFP-8–
772 (A),GFP-8–387 (B),GFP-101–387 (C) andGFP-N-alt-269–715 (D)
constructs were expressed in U251 cells. All constructs containing the a-
actinin binding sequence localize to dense regions in a periodic pattern
(see insets). The constructs with alternative amino-terminus lacking the
a-actinin binding sequence also demonstrate stress ﬁber localization but
do not show the periodic dense region pattern. Bar¼ 5 lm.3. Results and discussion
3.1. Identiﬁcation of the interaction sites between palladin and
a-actinin
A detailed characterization of the interaction between pall-
adin and a-actinin was performed using diﬀerent methods.
Demonstration of a direct interaction and mapping of the in-
teraction sites was initially done with the yeast two-hydrid
system. Several palladin inserts were cloned in bait vector and
cotransformed with a-actinin prey constructs. In these exper-
iments a short segment, amino acids 222–280, mediated an
interaction with a-actinin (Fig. 1A). None of the constructs
lacking this sequence bound to a-actinin. The palladin binding
site in a-actinin was located in the carboxy-terminal domain,
within EF-hand repeats 3–4 (Fig. 1B).
To conﬁrm the results with another method, we performed
aﬃnity precipitation assays with in vitro translated palladin
and GST-a-actinin constructs. Palladin polypeptides 8–772,
101–280 and 389–772 were tested with several a-actinin con-
structs. 101–280 segment was chosen, since according to the
yeast two-hybrid results the binding site is between amino
acids 222–280; 389–772 was tested, because the homologous
region in myopalladin has been suggested to mediate binding
to a-actinin [6]. In line with yeast two-hybrid results 8–772 and
101–280 bound a-actinin, whereas the carboxy-terminal pall-
adin construct did not show any binding (Fig. 2).
The experiments thus identiﬁed a sequence within residues
222–280 of palladin that was suﬃcient and necessary for
binding of the carboxy-terminal EF-hands 3–4 of a-actinin. A
homologous region in myotilin is also responsible for a-actininbinding (Taivainen et al., manuscript in preparation). Highest
homology between the proteins is seen within a short 17 resi-
due segment (64% identity and 94% similarity) (Fig. 3). It will
be interesting to test whether this novel a-actinin binding motif
interacts with EF-hand domains in other proteins. This se-
quence does not have features of any known structural do-
main, neither do homology searches identify related sequence
in myopalladin or any other known protein. Interestingly, the
region indicated in a-actinin binding in myopalladin (three
carboxy-terminal Ig-domains) [6] was not mediating a similar
interaction in palladin, although the sequences are 63% iden-
tical. The binding region in the EF-hand repeats 3–4 of a-
actinin’s carboxy-terminal domain is common to myopalladin,
palladin and myotilin and also titin has been shown to bind the
same region of a-actinin [23]. The a-actinin binding site in
cardiac titin resides within Z-repeat 7, which shows no ho-
mology to the binding site in palladin and myotilin. As all
these molecules are expressed in striated muscle, it will be of
interest to further compare the molecular details such
as binding kinetics and functional consequences of each
interaction.
Fig. 6. Localization of a-actinin R1–R4EF in cells expressing mitoc-
hondrially targeted palladin constructs. CHO cells were cotransfected
with GFP–a-actinin R1–R4EF and with palladin 8-387-MOM-BiPro,
222–280-MOM-BiPro or MOM-BiPro vector containing an outer
mitochondrial membrane targeting sequence. MOM constructs were
detected with BiPro tag mAb. GFP–a-actinin R1–R4EF construct
transfected with the MOM-BiPro vector is distributed diﬀusely in the
cytoplasm. When cotransfected with palladin MOM constructs, a-
actinin is recruited to the mitochondrial membrane. Bar¼ 5 lm.
Fig. 5. Palladin 8–772 targets a-actinin to actin ﬁlaments. COS-7 cells were transfected with palladin constructs GFP-8–772 palladin or GFP-N-alt-
269–715. Cells were stained for endogenous a-actinin. Two examples of palladin 8–772 expressing cells with thick irregularly shaped and oriented
actin bundles are shown. Both palladin (top) and a-actinin (bottom) are recruited into the ﬁlaments. Palladin N-alt-269–715 (two right panels)
induces actin-containing aggregates but does not redistribute a-actinin into these structures. Bar¼ 20 lm.
M. R€onty et al. / FEBS Letters 566 (2004) 30–34 333.2. Role of interaction sites in targeting of a-actinin and
palladin
To study the interaction in vivo, we used transfection-based
targeting assays. First, we analyzed how diﬀerent palladin
constructs are targeted in cells. Three of the constructs (8–772,
8–387 and 101–387) interacted in biochemical assays with a-
actinin (Fig. 4). The fourth one is a cDNA variant (N-alt-269–
715), in which a unique amino-terminal sequence is fused to the
published sequence at residue 269. The variant amino-terminal
sequence did not bind a-actinin in yeast two-hybrid analysis
(not shown). All four constructs, when expressed as GFP fusion
proteins, were associated with actin ﬁlaments. However, only
those containing the identiﬁed a-actinin binding site localized
in dense regions suggesting that the interaction with a-actinin
plays a role in targeting of palladin. In reciprocal experiments,
the ability of palladin to redistribute endogenous or transfected
a-actinin was tested. In one set of experiments, we used COS
cells that have a poorly arranged cytoskeleton without stress
ﬁbers and which can be easily modulated with actin-organizing
proteins [17]. Transfection of palladin GFP-8–772 resulted in
the formation of robust actin bundles, a phenomenon seen also
in astrocytes [18]. The majority of palladin 8–772 was included
in these bundles (Fig. 5). Further analysis indicated that also a-
actinin was targeted to these bundles and the staining patterns
were highly overlapping. In COS-7 cells palladin N-alt-269–715
formed aggregates, which also contained F-actin (not shown).
However, a-actinin was not targeted to these structures (Fig. 5).
Since the ability of palladin to target a-actinin might be indirect
and related to its actin bundling ability, we further analyzed the
targeting mechanism by using a MOM-targeting vector with a
birch proﬁlin tag. In this assay, palladin constructs were co-
transfected with GFP–a-actinin lacking the actin-binding do-
main (R1–R4EF). This a-actinin construct has been shown to
retain in the cytoplasm and lead to disruption of the actin cy-
toskeleton [21]. The diﬀuse staining pattern was conﬁrmed also
in CHO cells transfected with R1–R4EF alone (Fig. 6). Short
palladin inserts (8–387, 222–280) containing the identiﬁed a-
actinin binding site were cloned into MOM-vector and trans-
fected with GFP–a-actinin R1–R4EF construct into CHO cells.
The proper mitochondrial targeting was veriﬁed with anti-BiPro mAb. Cotransfection of R1–R4EF together with
MOM-8–387 or MOM-222–280 resulted in recruitment of the
a-actinin R1–R4EF from diﬀuse cytoplasmic localization to the
34 M. R€onty et al. / FEBS Letters 566 (2004) 30–34mitochondria (Fig. 6), whereas MOM vector alone did not
induce any changes in the distribution of R1–R4EF.
The aﬃnity of the interaction between myotilin and a-ac-
tinin is exceptionally high for cytoskeletal proteins (KD 6 nM)
(Taivainen et al., manuscript in preparation). The binding
kinetics was not measured here, but the similarity of the a-
actinin binding sequence in myotilin and palladin together
with the remarkable ability of palladin to target a-actinin
suggests a stable and high aﬃnity interaction. This conclusion
is further supported by high degree of colocalization between
palladin and a-actinin in various subcellular structures
(Gorshkov et al., unpublished). In conclusion, the results in-
dicate that the interaction between palladin and a-actinin is
important for bidirectional targeting of these proteins. In the
future, targeted down-regulation of palladin should clarify the
functional importance of the interaction in localization and
function of these proteins. The studies will also provide further
information on the formation and maintenance of dense re-
gions and other structures containing palladin and a-actinin.
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